# Insurance Denials for Brand-Name Drugs Surge Rejection rates for non-generic drugs increased by 67% between 2018-2024. - **Source:** [Reddit Science](https://brifing.si/source/1294ffb3-9f44-431d-8cd2-05584c8d9014) - **Published:** 2026-07-12 - **Topic:** [Finance](https://brifing.si/c/finance) - **Original article:** - **On Brifing:** https://brifing.si/s/adbf2567-9fa5-40a0-b7b1-a5139a94e061 ## Sharp Increase in Denial Rates Insurance denials for initial brand-name prescription requests without generic alternatives have risen by 67% since 2018. This trend reflects cost containment policies in healthcare spending. ## Barriers to Patient Access Denial decisions can delay patients' access to timely treatment. For chronic disease patients especially, these delays may lead to serious health complications. ## Growing Administrative Burden Physicians and pharmacists face increased paperwork for denied prescriptions. This added workload reduces system efficiency while straining healthcare providers. ## Cost-Care Balancing Act While insurers aim to control costs, maintaining balance with optimal patient care becomes challenging. Experts warn short-term savings might increase long-term healthcare expenditures. ## Patient Advocacy Movements Patient associations are mobilizing against rising denial rates, demanding greater transparency in insurers' decision-making processes regarding prescription approvals. ## Need for Systemic Reform Experts emphasize that increasing denial rates necessitate structural healthcare reforms. Smart solutions balancing cost control with patient access are being sought. ## Sources covering this story - https://www.reddit.com/r/science/comments/1uut3ru/insurance_denials_of_first_attempts_to_fill/ — --- _Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._